NCT04173858View on ClinicalTrials.gov

Evaluation of the Quality of Life of Patients With Opioid-induced Constipation Under Treatment With Naloxegol

CompletedOBSERVATIONAL

Enrollment

126

Participants

Timeline

Start Date

September 21, 2017

Primary Completion Date

October 31, 2019

Study Completion Date

October 31, 2019

Conditions

Opioid-induced Constipation

Interventions

DRUG

Naloxegol

25 mg oral naloxegol once daily.

Trial Locations (1)

28850

Hospital Universitario de Torrejon, Torrejón de Ardoz

All Listed Sponsors

lead

Kyowa Kirin Farmacéutica S.L.U.

INDUSTRY

NCT04173858 - Evaluation of the Quality of Life of Patients With Opioid-induced Constipation Under Treatment With Naloxegol | Biotech Hunter | Biotech Hunter